Molecular Diagnostics Center
view more >>
- About MEDx
- Technology Centers
- Pharma Solutions
-
CDx/IVD Products
IHC-Based AssaysPCR-Based AssaysNGS-Based AssaysMore AssaysCustomized Assays - Clinical Testing
- Quality Systems
- Events
- Contact Us
- 280+Pharmaceutical Partners
- 150+Biomarker Assays
- 300+Method Validations
- 40+CDx
Technology Centers
Comprehensive Translational Medicine
Pharma Solutions
CDO Enabling Drug R&D
CDx/IVD Products
The Leader of Companion Diagnostics Total-Solution Providers
Clinical Testing
Patient Testing for Precision Medicine
-
Pan solid tumor
Meet the diverse demands from clinicians and patients, MEDx Translational Medicine (MEDx) has developed a series of solid tumor tests, including pan-cancer gene panel tests, single cancer gene panel assays, and immunohistochemistry (IHC). -
Hematologic Malignancy
Most recently, molecular diagnostic products using PCR and next-generation sequencing (NGS) have significantly improved the understanding of molecular mechanism of hematological malignancies, leading to the right choice of molecular targeting drugs for precision therapy for the individual patients in clinic.
Quality Systems
State-of-Art Facilities & Global-standard Quality Systems
About MEDx
Translational Medicine
MEDx Translational Medicine Co., Ltd (simply MEDx) was founded in 2013, formerly known as QIAGEN (Suzhou) Translational Medicine Co., Ltd.Obtained with comprehensive technology platforms, high quality system, and strong IVD R&D experience, MEDx has become a leading innovative company in companion diagnostics and the total solution provider for precision medicine in China.
Taking advantage of the comprehensive translational platforms including genomics, proteomics, cytomics, and pathology, MEDx offers integrated solutions from biomarker discovery, target validation, molecular testing, and patient stratification for drug clinical trials, to the IVD/CDx R&D and commercialization. With a world-class technical team and a rich IVD/CDx pipeline, MEDx collaborates with hundreds of world-renowned pharmaceutical companies.
Events
-
23 Nov 2023MEDx and illumina jointly promote gene sequencing technology to help global new drug researchview more >>
23 Nov 2023MEDx and illumina jointly promote gene sequencing technology to help global new drug researchview more >>
-
25 Aug 2023MEDx's Debut at 2023 Medlab Asia & Asia Health a Complete Successview more >>
25 Aug 2023MEDx's Debut at 2023 Medlab Asia & Asia Health a Complete Successview more >>
- MEDx and illumina jointly promote gene sequencing technology to help global new drug research
-
In the development process of innovative drugs, the accompanying diagnosis is like a indicating lamp
- MEDx's Debut at 2023 Medlab Asia & Asia Health a Complete Success
-
From August 16 to 18, MEDx participated in the 2023 MedLab Asia held at the IMPACT Exhibition Centre
- MEDx Partners with Junshi Biosciences in the Innovative Co-Development of Companion Diagnostics
-
On May 22, 2023, Shanghai Junshi Biosciences Co., Ltd. (hereinafter referred to as "Junshi Bios
- HRD Panel of MEDx
-
Homologous Recombination Repair (HRR) and Poly ADP-ribose Polymerase (PARP) Repair are two important
- MEDx Obtained the Global Authorization of Abcam
-
MEDx announced the expansion of global cooperation with its strategic partner Abcam (AIM:ABC; NASDAQ
- Meet MEDx at Medlab Middle East | Dubai 2023
-
The leading healthcare event –Medlab Middle East is coming. Spread over 45,000 sqm of space, this c
- What is minimal residual disease (MRD)?
-
Minimal Residual Disease (MRD) was initially proposed in blood disorders, which refers to the presen
- A Potential CDx Biomarker For Targeted Therapy In Non-Small Cell lung Cancer——MET
-
The morbidity and mortality of lung cancer rank first among malignant tumors, and the disease burden
- MEDx NGS Panel Solutions in Solid Tumors
-
Next-generation sequencing (NGS) can simultaneously sequence millions or even billions of DNA molecu
- MEDx NGS Panel Solutions in Solid Tumors
-
Next-generation sequencing (NGS) can simultaneously sequence millions or even billions of DNA molecu
- Companion Diagnostics- an Effective Tool for Medication Guidance
-
A companion diagnostic (CDx) is a medical device, often an in vitro device, which provides informati
Follow MEDx
